(Re-)defining “successful aging” as the endpoint in clinical trials?: Current methods, challenges, and emerging solutions

“Successful aging” as defined in Rowe & Kahn’s model aims to include the major domains of aging under a single overarching concept. From here the question arises how “successful aging” itself can be implemented as an endpoint in clinical research in a way that it is compliant to methodological r...

Full description

Saved in:
Bibliographic Details
Main Author: Schönstein, Anton (Author)
Format: Article (Journal)
Language:English
Published: January 2025
In: The gerontologist
Year: 2025, Volume: 65, Issue: 1, Pages: 1-6
ISSN:1758-5341
DOI:10.1093/geront/gnae058
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/geront/gnae058
Get full text
Author Notes:Anton Schönstein, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1937094413
003 DE-627
005 20250930114511.0
007 cr uuu---uuuuu
008 250926s2025 xx |||||o 00| ||eng c
024 7 |a 10.1093/geront/gnae058  |2 doi 
035 |a (DE-627)1937094413 
035 |a (DE-599)KXP1937094413 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 11  |2 sdnb 
100 1 |a Schönstein, Anton  |d 1992-  |e VerfasserIn  |0 (DE-588)1235701484  |0 (DE-627)1760713155  |4 aut 
245 1 0 |a (Re-)defining “successful aging” as the endpoint in clinical trials?  |b Current methods, challenges, and emerging solutions  |c Anton Schönstein, PhD 
264 1 |c January 2025 
300 |b Illustrationen 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 30 May 2024 
500 |a Gesehen am 26.09.2025 
520 |a “Successful aging” as defined in Rowe & Kahn’s model aims to include the major domains of aging under a single overarching concept. From here the question arises how “successful aging” itself can be implemented as an endpoint in clinical research in a way that it is compliant to methodological regulatory framework and recommendations as formulated, for example, by the United States Food and Drug Admnistration (FDA). This article discusses from an applied perspective approaches and examples of how “successful aging” as a multidomain concept can be put into measurement practice.Narrative literature review.Existing methods of merging insights from, for example, functional, social, and cognitive outcomes can fail to perform under conditions of extreme heterogeneity, as often present in samples of older adults. In research on rare diseases, the methodological approach of a Multidomain Responder Index (MDRI) has been proposed to handle heterogeneity. MDRIs may also provide a solution to combine aging outcomes from different domains into a single “successful aging” endpoint. However, strict measurement criteria will need to be fulfilled to find acceptance in decision making and validated meaningful change thresholds are a critical prerequisite.Gerontology can spearhead methodological approaches of handling multidimensional measurement under heterogeneity by validating a “successful aging” MDRI suitable for use as an endpoint in clinical research. 
773 0 8 |i Enthalten in  |t The gerontologist  |d Oxford : Oxford Univ. Press, 1961  |g 65(2025), 1 vom: Jan., Artikel-ID gnae058, Seite 1-6  |h Online-Ressource  |w (DE-627)327645482  |w (DE-600)2043844-8  |w (DE-576)105283029  |x 1758-5341  |7 nnas  |a (Re-)defining “successful aging” as the endpoint in clinical trials? Current methods, challenges, and emerging solutions 
773 1 8 |g volume:65  |g year:2025  |g number:1  |g month:01  |g elocationid:gnae058  |g pages:1-6  |g extent:6  |a (Re-)defining “successful aging” as the endpoint in clinical trials? Current methods, challenges, and emerging solutions 
856 4 0 |u https://doi.org/10.1093/geront/gnae058  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250926 
993 |a Article 
994 |a 2025 
998 |g 1235701484  |a Schönstein, Anton  |m 1235701484:Schönstein, Anton  |d 850000  |d 851600  |e 850000PS1235701484  |e 851600PS1235701484  |k 0/850000/  |k 1/850000/851600/  |p 1  |x j  |y j 
999 |a KXP-PPN1937094413  |e 4776306514 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"issue":"1","year":"2025","text":"65(2025), 1 vom: Jan., Artikel-ID gnae058, Seite 1-6","extent":"6","pages":"1-6","volume":"65"},"note":["Gesehen am 08.08.2022"],"pubHistory":["1.1961 -"],"id":{"eki":["327645482"],"zdb":["2043844-8"],"issn":["1758-5341"]},"origin":[{"publisherPlace":"Oxford ; Washington, DC","publisher":"Oxford Univ. Press ; Soc.","dateIssuedKey":"1961","dateIssuedDisp":"1961-"}],"name":{"displayForm":["The Gerontological Society of America"]},"recId":"327645482","disp":"(Re-)defining “successful aging” as the endpoint in clinical trials? Current methods, challenges, and emerging solutionsThe gerontologist","person":[{"display":"Wahl, Hans-Werner","role":"edt","given":"Hans-Werner","family":"Wahl"}],"title":[{"title":"The gerontologist","title_sort":"gerontologist"}],"corporate":[{"role":"isb","display":"Gerontological Society of America"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"]}],"note":["Veröffentlicht: 30 May 2024","Gesehen am 26.09.2025"],"name":{"displayForm":["Anton Schönstein, PhD"]},"recId":"1937094413","id":{"eki":["1937094413"],"doi":["10.1093/geront/gnae058"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"January 2025"}],"language":["eng"],"physDesc":[{"noteIll":"Illustrationen","extent":"6 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Schönstein, Anton","given":"Anton","role":"aut","family":"Schönstein"}],"title":[{"title_sort":"(Re-)defining “successful aging” as the endpoint in clinical trials?","title":"(Re-)defining “successful aging” as the endpoint in clinical trials?","subtitle":"Current methods, challenges, and emerging solutions"}]} 
SRT |a SCHOENSTEIREDEFINING2025